ILC Therapeutics
Alan is an experienced CEO with 51 years’ experience in big and small pharma and biotech. He spent 28 years in Warner Lambert and eight years as commercial head of ProStrakan before becoming joint (co-founder) CEO Internis until exit. Recently Alan was CEO of Ryboquin, the gene engineering company, and Nanogenics, which was acquired by Ryboquin.
This person is not in any offices
ILC Therapeutics
ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.